Arlene Weintraub

March 23, 2022

Bone pain is a common symptom that patients with multiple myeloma face, but some may find relief with treatments and exercise.

September 13, 2021

Immunotherapy and tyrosine kinase inhibitors may potentially change the treatment paradigm for patients with renal cell carcinoma, the most common type of kidney cancer in adults.

June 16, 2021

BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.

April 27, 2021

Second opinions may enhance your treatment plan or even change your course.

February 12, 2021

Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.

October 30, 2020

Ultra-precise drug targeting brings new hope for patients with non-small cell lung cancer that harbors rare mutations.

September 22, 2020

Exciting advances in treatment options for patients with mantle cell lymphoma are greatly improving the outlook for long-term remissions.

July 17, 2020

In both diagnosis and treatment of cancer, there is a growing role for radiation drugs that are injected, ingested or inserted.

June 24, 2020

New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.

April 22, 2020

Less invasive surgery and more focused radiation can ease treatment for patients with lung cancer — at any stage.

November 16, 2019

Cancer can trigger symptoms that seem as mysterious as their name: paraneoplastic syndromes.

September 25, 2019

A look back at how immunotherapy began in oncology.

September 17, 2019

New technologies boost safety for patients with cancer who need donated blood.

August 30, 2019

A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.

May 24, 2019

Emerging facts about the genetics that drive gastric cancer are leading to new treatments for the disease.

May 06, 2019

Testing for genomic mutations in lung cancer helps pinpoint targeted therapies.

February 13, 2019

Researchers are using innovative technology to hunt down hidden cancer cells.

December 15, 2018

Men with advanced prostate cancer may benefit from genomic testing as BRCA and other gene mutations play a bigger role in guiding treatment.

October 30, 2018

After treatment, remaining breast cancer cells can lie dormant for years before causing a recurrence. Researchers are investigating how to stop them.

July 30, 2018

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.

May 01, 2018

Immune and targeted therapies build hope for patients with advanced lung cancer.

March 18, 2018

Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.

December 16, 2017

One-fifth of all cancers are caused by viral infections. New treatment and prevention strategies are in the works.

September 14, 2017

Immunotherapies known as checkpoint inhibitors are so promising in bladder cancer that many patients want them as first treatments — before they’ve been proven in that setting.

August 10, 2017

Zuniga enjoys mentoring other patients as part of her volunteer work with the Arizona Carcinoid and Neuroendocrine Cancer Foundation. In February, she helped organize a panel discussion with physicians from Banner MD Anderson Cancer Center in Gilbert, Arizona, which was simulcast online so patients anywhere could learn about new treatment options and therapies that are in development.

August 09, 2017

Patients with neuroendocrine tumors have more treatment options than ever before.

April 17, 2017

Screening and preventative surgery are common strategies for those with inherited predispositions to cancer.

March 07, 2017

New guidelines offer a variety of screening tests for colorectal cancer, some of them noninvasive.

September 28, 2016

CURE gathered some need-to-know facts about bladder cancer, the sixth most common cancer.

September 27, 2016

For decades, research into bladder cancer treatments was stagnant, but now science has moved into a period rife with new approaches — immunotherapy chief among them.